» Articles » PMID: 28513825

Loss of TET1 Facilitates DLD1 Colon Cancer Cell Migration Via H3K27me3-mediated Down-regulation of E-cadherin

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2017 May 18
PMID 28513825
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic modifications such as histone modifications and cytosine hydroxymethylation are linked to tumorigenesis. Loss of 5-hydroxymethylcytosine (5 hmC) by ten-eleven translocation 1 (TET1) down-regulation facilitates tumor initiation and development. However, the mechanisms by which loss of TET1 knockdown promotes malignancy development remains unclear. Here, we report that TET1 knockdown induced epithelial-mesenchymal transition (EMT) and increased cancer cell growth, migration, and invasion in DLD1 cells. Loss of TET1 increased EZH2 expression and reduced UTX-1 expression, thus increasing histone H3K27 tri-methylation causing repression of the target gene E-cadherin. Ectopic expression of the H3K27 demethylase UTX-1 or EZH2 depletion both impeded EZH2 binding caused a loss of H3K27 methylation at epithelial gene E-cadherin promoter, thereby suppressing EMT and tumor invasion in shTET1 cells. Conversely, UTX-1 depletion and ectopic expression of EZH2 enhanced EMT and tumor metastasis in DLD1 cells. These findings provide insight into the regulation of TET1 and E-cadherin and identify EZH2 as a critical mediator of E-cadherin repression and tumor progression.

Citing Articles

Mesenchymal stem cells modulate breast cancer progression through their secretome by downregulating ten-eleven translocation 1.

Motamed R, Jabbari K, Sheikhbahaei M, Ghazimoradi M, Ghodsi S, Jahangir M Sci Rep. 2025; 15(1):6593.

PMID: 39994414 PMC: 11850621. DOI: 10.1038/s41598-025-91314-3.


NOP2 facilitates EZH2-mediated epithelial-mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression.

Yang Y, Fan H, Liu H, Lou X, Xiao N, Zhang C Cell Death Dis. 2024; 15(7):506.

PMID: 39013911 PMC: 11252406. DOI: 10.1038/s41419-024-06899-w.


A novel role of prognostic nutritional index in predicting the effectiveness of infliximab in Crohn's disease.

Peng Z, Xu D, Li Y, Liu X, Li F, Peng Y Ann Med. 2023; 55(1):2236011.

PMID: 37477647 PMC: 10364561. DOI: 10.1080/07853890.2023.2236011.


PLU1 Promotes the Proliferation and Migration of Glioma Cells and Regulates Metabolism.

Dong W, Wang L, Pan Y, Tu Q, He T, Zhou T Technol Cancer Res Treat. 2023; 22:15330338231175768.

PMID: 37254514 PMC: 10240554. DOI: 10.1177/15330338231175768.


KDM4B down-regulation facilitated breast cancer cell stemness via PHGDH upregulation in H3K36me3-dependent manner.

Wang X, Li H, Xia R, Li X, Zhang X, Jin T Mol Cell Biochem. 2023; 479(4):915-928.

PMID: 37249813 DOI: 10.1007/s11010-023-04777-1.